ClinicalTrials.Veeva

Menu

Leukocyte Esterase Sensor Test

Rothman Institute Orthopaedics logo

Rothman Institute Orthopaedics

Status

Unknown

Conditions

Prosthetic Joint Infection

Treatments

Diagnostic Test: leukocyte esterase electrochemical assay

Study type

Observational

Funder types

Other

Identifiers

NCT04390607
2020Cleu

Details and patient eligibility

About

The primary objective of this study is to assess the diagnostic efficacy of the quantitative electrochemical LE biosensor for periprosthetic joint infection (PJI). The secondary objective of this study is to assess the utility of d-lactase as adjunct biomarker to LE in making a diagnosis of PJI.

Enrollment

230 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1: consecutive patients undergoing at least one of the following procedures: presumed aseptic revision arthroplasty, irrigation and debridement, radical resection for periprosthetic joint infection

Exclusion criteria

  1. known active gout flare
  2. existing corrosion or metallosis
  3. inflammatory arthritis
  4. preexisting diagnosis of infection in the same joint
  5. patients undergoing second-stage procedure for infection.

Trial design

230 participants in 1 patient group

Subjects undergoing revision joint surgery
Treatment:
Diagnostic Test: leukocyte esterase electrochemical assay

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems